Overview
Mark Burge is an Endocrinologist in Albuquerque, New Mexico. Dr. Burge is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. His top areas of expertise are Peripheral Neuropathy, Diabetic Neuropathy, Klinefelter Syndrome, Vitamin D Deficiency, and Thyroidectomy.
His clinical research consists of co-authoring 48 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2211 Lomas Blvd NE, Albuquerque, NM 87106
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Presbyterian Healthcare Services
May Reyes is an Endocrinologist in Albuquerque, New Mexico. Dr. Reyes is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Hyperplasia. Her top areas of expertise are Thyroid Nodule, Hypothyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism.
Presbyterian Healthcare Services
Mansi Mehta is an Endocrinologist in Albuquerque, New Mexico. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Hyperplasia. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Thyroid Cancer, and Follicular Thyroid Cancer.
Presbyterian Healthcare Services
Lisa Mcguire is an Endocrinologist in Albuquerque, New Mexico. Dr. Mcguire is rated as an Advanced provider by MediFind in the treatment of Parathyroid Hyperplasia. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Neonatal Severe Hyperparathyroidism, and Familial Isolated Hyperparathyroidism.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Peripheral NeuropathyDr. Burge isDistinguished. Learn about Peripheral Neuropathy.
- Advanced
- Diabetic NeuropathyDr. Burge isAdvanced. Learn about Diabetic Neuropathy.
- Experienced
- Addison's DiseaseDr. Burge isExperienced. Learn about Addison's Disease.
- Anaplastic Thyroid CancerDr. Burge isExperienced. Learn about Anaplastic Thyroid Cancer.
- CalcinosisDr. Burge isExperienced. Learn about Calcinosis.
- Congenital HyperinsulinismDr. Burge isExperienced. Learn about Congenital Hyperinsulinism.
- Diabetic KetoacidosisDr. Burge isExperienced. Learn about Diabetic Ketoacidosis.
- Diabetic RetinopathyDr. Burge isExperienced. Learn about Diabetic Retinopathy.